Novartis AG
NVS
Company Profile
Business description
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Contact
Lichtstrasse 35
Basel 4056
CHET: +41 613241111
E: investor.relations@novartis.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
76,057
Novartis AG News & Analysis
stocks
Magnificent Seven vs. the ‘Granolas’: How does Europe’s version stack up?
‘Granolas’ stocks are profitable, diversified, cheap—and posting big returns.
stocks
Best international companies to own: 2023 Edition
These companies from various corners of the globe are well positioned for the future.
markets
Asian markets are globalising
In an era of onshoring and localisation, revenue sources show an increasingly interconnected world economy
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,150.10 | 129.20 | 1.61% |
| CAC 40 | 8,204.16 | 35.83 | -0.43% |
| DAX 40 | 18,819.02 | 50.34 | -0.27% |
| Dow JONES (US) | 39,908.00 | 349.89 | 0.88% |
| FTSE 100 | 8,429.00 | 16.80 | -0.20% |
| HKSE | 19,376.53 | 302.82 | 1.59% |
| NASDAQ | 16,742.39 | 231.21 | 1.40% |
| Nikkei 225 | 38,920.26 | 534.53 | 1.39% |
| NZX 50 Index | 11,728.06 | 202.18 | 1.75% |
| S&P 500 | 5,308.15 | 61.47 | 1.17% |
| S&P/ASX 200 | 7,881.30 | 127.60 | 1.65% |
| SSE Composite Index | 3,122.40 | 2.50 | 0.08% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.05 | 0.00 | 2.13% |
| Telstra Group Ltd TLS | 3.69 | 0.02 | 0.55% |
| South32 Ltd S32 | 3.75 | 0.08 | 2.18% |
| PYC Therapeutics Ltd PYC | 0.10 | 0.01 | -7.62% |
| Pilbara Minerals Ltd PLS | 4.01 | 0.03 | 0.75% |
| Incitec Pivot Ltd IPL | 2.97 | 0.15 | 5.32% |
| Red 5 Ltd RED | 0.49 | 0.02 | 4.26% |
| Pantoro Ltd PNR | 0.09 | 0.01 | 7.41% |
| Vicinity Centres VCX | 1.98 | 0.05 | 2.60% |
| Mirvac Group MGR | 2.15 | 0.06 | 2.87% |